Global Multiple Sclerosis Therapies Market by Type (Immunosuppressants and Immunomodulators) and Route of Administration (Oral, Injectable, and Intravenous) and Regional Forecasting 2020-2027.

BIZ4192996
200 Pages
February 2021
Pharmaceuticals

Download Sample Get Discount

Global Multiple Sclerosis Therapies Market was valued at USD 23.6 Billion in 2019 and expected to grow with a CAGR 2.5% over the forecast period 2020-2027. Multiple sclerosis is a disease in which immune system eats away at the shielding encompassing of nerves. Multiple sclerosis is an inflammatory medical condition which results in axonal transection, neurodegeneration of the nerve cells of the brain and spinal cord and demyelination. It is devastating disease-causing coordination functions of the body and disruption in communication. Some of the other symptoms are numbness, spasticity, fatigue, cognitive changes, emotional changes, bladder dysfunction and depression. This disease broadly classified in RRMS(Relapsing-remitting Multiple Sclerosis), SPMS(Secondary-progressive multiple sclerosis), PPMS(Primary-Progressive Multiple Sclerosis), and PRMS(Progressive-Relapsing MS). Multiple Sclerosis therapies include – counselling, support group, acupuncture and physical therapy. Upsurge in patient population and increase in number of pipeline drugs are key drivers of the global multiple sclerosis therapies market. For instance, as per Statista, the number of pipeline drugs have increased, from 2001, there were 5,995 drugs in the R&D pipeline to 16,181 drugs in the pipeline in 2019. Furthermore, surge in number of patient assistance programs (PAPs) also support in market growth. Despite that, unspecified etiology restrains the market growth over the forecasting period 2020-2027.

The regional analysis of the Multiple Sclerosis Therapies Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America dominates the market owing to increase in demand for MS therapeutic products and increase favorable reimbursement policies. However, APAC also participating in market growth due to improved distribution networking of pharmaceutical company in the region.

Key Players in Global Multiple Sclerosis Therapies Market

Abbvie Inc.

Bayer AG

Biogen

Bristol-Myers Squibb Company

F. Hoffmann-La Roche Ltd.

Merck KGAA

Novartis AG

Pfizer Inc.

Sanofi

Teva Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Immunosuppressants

Immunomodulators

By Route of Administration:

Oral

Injectable

Intravenous

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

Asia Pacific

China

India

Japan

Australia

Latin America

Brazil

Mexico

Rest of LA

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of Global Multiple Sclerosis Therapies Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Multiple Sclerosis Therapies Market, by Type, 2018-2027 (USD Billion)

1.2.2. Multiple Sclerosis Therapies Market, by Route of Administration, 2018-2027 (USD Billion)

1.2.3. Multiple Sclerosis Therapies Market, By Region, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Multiple Sclerosis Therapies Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Multiple Sclerosis Therapies Market Dynamics

3.1. Multiple Sclerosis Therapies Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Multiple Sclerosis Therapies Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economic

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Multiple Sclerosis Therapies Market, by Type

5.1. Market Snapshot

5.2. Global Multiple Sclerosis Therapies Market by Source, Performance - Potential Analysis

5.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Type 2018-2027 (USD Billion)

5.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis

5.4.1. Immunosuppressants

5.4.2. Immunomodulators

Chapter 6. Global Multiple Sclerosis Therapies Market, by Route of Administration

6.1. Market Snapshot

6.2. Global Multiple Sclerosis Therapies Market by Source, Performance - Potential Analysis

6.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)

6.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis

6.4.1. Oral

6.4.2. Injectable

6.4.3. Intravenous

Chapter 7. Global Multiple Sclerosis Therapies Market, Regional Analysis

7.1. Multiple Sclerosis Therapies Market, Regional Market Snapshot

7.2. North America Multiple Sclerosis Therapies Market

7.2.1. U.S. Multiple Sclerosis Therapies Market

7.2.1.1. Type breakdown estimates & forecasts, 2018-2027

7.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Multiple Sclerosis Therapies Market

7.3. Europe Multiple Sclerosis Therapies Market Snapshot

7.3.1. U.K. Multiple Sclerosis Therapies Market

7.3.2. Germany Multiple Sclerosis Therapies Market

7.3.3. France Multiple Sclerosis Therapies Market

7.3.4. Spain Multiple Sclerosis Therapies Market

7.3.5. Italy Multiple Sclerosis Therapies Market

7.3.6. Rest of Europe Multiple Sclerosis Therapies Market

7.4. Asia-Pacific Multiple Sclerosis Therapies Market Snapshot

7.4.1. China Multiple Sclerosis Therapies Market

7.4.2. India Multiple Sclerosis Therapies Market

7.4.3. Japan Multiple Sclerosis Therapies Market

7.4.4. Australia Multiple Sclerosis Therapies Market

7.5. Latin America Multiple Sclerosis Therapies Market Snapshot

7.6. Rest of The World Multiple Sclerosis Therapies Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profile

8.2.1. Abbvie Inc.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Bayer AG

8.2.3. Biogen

8.2.4. Bristol-Myers Squibb Company

8.2.5. F. Hoffmann-La Roche Ltd.

8.2.6. Merck KGAA

8.2.7. Novartis AG

8.2.8. Pfizer Inc.

8.2.9. Sanofi

8.2.10. Teva Pharmaceutical Industries Ltd.

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Multiple Sclerosis Therapies Market, report scope

TABLE 2. Global Multiple Sclerosis Therapies Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Multiple Sclerosis Therapies Market estimates & forecasts by Type, 2018-2027 (USD Billion)

TABLE 4. Global Multiple Sclerosis Therapies Market estimates & forecasts by Route of Administration, 2018-2027 (USD Billion)

TABLE 5. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Multiple Sclerosis Therapies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Multiple Sclerosis Therapies Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. U.S. Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. U.S. Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. U.S. Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Canada Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Canada Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. UK Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. UK Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. Germany Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. Germany Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. France Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. France Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Spain Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Spain Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Italy Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Italy Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. China Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. China Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. China Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. India Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. India Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. India Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Japan Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. Japan Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. Japan Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Australia Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Australia Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Latin America Multiple Sclerosis Therapies Market estimate & forecasts, 2018-2027 (USD Billion)

TABLE 54. ROW Multiple Sclerosis Therapies Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. ROW Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. ROW Multiple Sclerosis Therapies Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. List of secondary sources, used in the study of global Multiple Sclerosis Therapies Market

TABLE 58. List of primary sources, used in the study of global Multiple Sclerosis Therapies Market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Multiple Sclerosis Therapies Market by Type (Immunosuppressants and Immunomodulators) and Route of Administration (Oral, Injectable, and Intravenous) and Regional Forecasting 2020-2027.

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara